Work

105 Assessing CEACAM1 blockade as a therapeutic strategy using a CRISPR-Cas9-based mouse melanoma model

Year: 2018

Type: article

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2018.03.109

Authors: C. Rauck, E. Perez-Guijarro, C. Day, G. Merlino

Institutions: National Institutes of Health, National Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2801831440

FWCI:

Cites:

Cited by:

Related to: 10